Evidence map›Paper›PMID 26885271›Full record

ArticleAmerican journal of translational research2015

Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart.

Tohru Hosoyama, Makoto Samura, Tomoaki Kudo, Arata Nishimoto, Koji Ueno, Tomoaki Murata, Takashi Ohama, Koichi Sato, Akihito Mikamo, Koichi Yoshimura and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Comparing theJournal of stem cells & regenerative medicine · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tohru HosoyamaDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Center for Regenerative Medicine, Yamaguchi University Graduate School of MedicineUbe, Japan.
Makoto SamuraDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Tomoaki KudoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Arata NishimotoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Koji UenoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Center for Regenerative Medicine, Yamaguchi University Graduate School of MedicineUbe, Japan.
Tomoaki MurataInstitute of Laboratory Animals, Yamaguchi University Graduate School of Medicine Ube, Japan.
Takashi OhamaLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University Yamaguchi, Japan.
Koichi SatoLaboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University Yamaguchi, Japan.
Akihito MikamoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Koichi YoshimuraDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Graduate School of Health and Welfare, Yamaguchi Prefectural UniversityYamaguchi, Japan.
Tao-Sheng LiDepartment of Stem Cell Biology, Atomic Bomb Disease Institute, Nagasaki University Nagasaki, Japan.
Kimikazu HamanoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Yamaguchi University · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiosphere-derived cells (CDCs) isolated from postnatal heart tissue are a convenient and efficientresource for the treatment of myocardial infarction. However, poor retention of CDCs in infarcted hearts often causes less than ideal therapeutic outcomes. Cell sheet technology has been developed as a means of permitting longer retention of graft cells, and this therapeutic strategy has opened new avenues of cell-based therapy for severe ischemic diseases. However, there is still scope for improvement before this treatment can be routinely applied in clinical settings. In this study, we investigated whether hypoxic preconditioning enhances the therapeutic efficacy of CDC monolayer sheets. To induce hypoxia priming, CDC monolayer sheets were placed in an incubator adjusted to 2% oxygen for 24 hours, and then preconditioned mouse CDC sheets were implanted into the infarcted heart of old myocardial infarction mouse models. Hypoxic preconditioning of CDC sheets remarkably increased the expression of vascular endothelial growth factor through the PI3-kinase/Akt signaling pathway. Implantation of preconditioned CDC sheets improved left ventricular function inchronically infarcted hearts and reduced fibrosis. The therapeutic efficacy of preconditioned CDC sheets was higher than the CDC sheets that were cultured under normaxia condition. These results suggest that hypoxic preconditioning augments the therapeutic angiogenic and anti-fibrotic activity of CDC sheets. A combination of cell sheets and hypoxic preconditioning offers an attractive therapeutic protocol for CDC transplantation into chronically infarcted hearts.

Indexed as

cardiosphere-derived cellscell-based therapycell sheethypoxic preconditioningOld myocardial infarction

Identifiers

PMID26885271
PMCPMC4731671
OpenAlexW2412088449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.